Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care.
Saved in:
| Title: | Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care. |
|---|---|
| Authors: | Samajdar SS; Department of Diabetes and Allergy-Asthma Therapeutics Specialty Clinic, Kolkata, West Bengal India., Joshi S; Department of Endocrinology, Joshi Clinic, Mumbai, Maharashtra India., Saboo B; Department of Diabetology, DiaCare, Ahmedabad, Gujarat India., Mukherjee S; Department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata, West Bengal India., Misra A; Diabetes Foundation (India), New Delhi, India.; Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chirag Enclave, New Delhi, India.; National Diabetes, Obesity and Cholesterol Foundation (N-DOC), SDA, New Delhi, India. |
| Source: | Diabetology international [Diabetol Int] 2026 Jun 05; Vol. 17 (3), pp. 59. Date of Electronic Publication: 2026 Jun 05 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Japan Country of Publication: Japan NLM ID: 101553224 Publication Model: eCollection Cited Medium: Print ISSN: 2190-1678 (Print) Linking ISSN: 21901678 NLM ISO Abbreviation: Diabetol Int Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2190-1678 |
|---|---|
| DOI: | 10.1007/s13340-026-00910-9 |
